Contact Us

Boston Scientific Enteryx Device
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Boston Scientific Enteryx Device

Boston Scientific Enteryx Device Side Effects Lawsuits | Side Effects: Esophagus Leakage, Esophagus Swelling, Esophagus Ulcers, Death |  Defective Enteryx Device, Suspended Device Sales

Boston Scientific Enteryx Device Side Effects May Be Linked To Personal Injury Lawsuits

Boston Scientific Enteryx Device | Lawsuits, Lawyers | Side Effects: Esophagus Leakage, Esophagus Swelling, Esophagus Ulcers, Death, Serious Injury | Defective Enteryx Device, Faulty Components, Suspended Device Sales

The FDA  & Boston Scientific notified health care professionals and patients about serious adverse events, including death, occurring in patients treated with the Enteryx device. On September 23, 2005, Boston Scientific ordered a recall of all Enteryx Procedure Kits and Enteryx Injector Single Packs from commercial distribution. Additionally, Boston Scientific Corp. recently suspended sales of it's Enteryx Device after more than two dozen reports of problems. The notice was posted on the company's Web site, during  the week of September 19, 2005.

An estimated 3,800 patients have been treated with Enteryx device, which was approved in 2003 by the FDA. The company's recall notice stated some doctors accidentally punctured the wall of the esophagus while injecting the substance, causing adverse events. Boston Scientific sold about $5.5 million worth of Enteryx kits in 2004.

Based upon reports filed with the FDA, patients suffered leakage, swelling, and ulcers in the esophagus. One elderly patient died last year after a doctor accidentally hit the wall of the patients aorta, the body's largest artery. Boston Scientific Corp. said the U.S. Food and Drug Administration is looking into reports of one death and six injuries linked to the use of its treatment for acid-reflux disease. Boston Scientific, said the FDA is looking into its Enteryx device, an injectable treatment for acid reflux, after the death of an elderly woman last month, three weeks after treatment. The agency will try to determine whether the death was linked to the device or to physician technique.

We've reported this to the FDA and we're working cooperatively with them," said Paul Donovan, a Boston Scientific spokesman. FDA spokeswoman Kathleen Quinn confirmed the agency was reviewing the adverse events. The Enteryx treatment, which the company had identified as one of its top products in terms of sales growth potential involves the injection of a plastic substance into the esophagus to help protect patients from acid backing up from the stomach.

In July 2004, the company issued an alert to doctors about the product and is updating the product label. In the case of the patient who died, some of the polymer had been injected into the woman's aorta, which ruptured, causing her to bleed to death.

Legal Help For Victims Affected By Boston Scientific Enteryx Device

If you or a loved one suffered injuries from a Boston Scientific Enteryx device, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


Boston Scientific Enteryx DeviceRSS Feed

Judge Upholds $14.3 Million Jury Verdict Against Boston Scientific

Oct 12, 2016
On October 3, 2016, a West Virginia federal judge rejected Boston Scientific Corp.'s appeal to overturn a $14.3 million award to three plaintiffs over injuries allegedly caused by the Obtryx pelvic mesh devices. The judge said evidence and law supported the verdict. U.S. District Judge Joseph R. Goodwin upheld the November 2014 verdict that Boston Scientific had challenged, Law360 reports. The judge rejected Boston Scientific's contentions, including that the jury's decision went against the...

FDA Investigating Counterfeit Material in Boston Scientific Transvaginal Mesh

Apr 4, 2016
The Food and Drug Administration (FDA) has issued a safety alert based on allegations that Boston Scientific's transvaginal surgical mesh may contain counterfeit raw material. The FDA is examining these allegations to determine any necessary and appropriate actions. The agency said at this time it is not aware of any adverse health effects associated with the counterfeit materials. According to the FDA, manufacturers sometimes change the source of a raw material in a device after the device...

Recall for Boston Scientific Implantable Defibrillators

Mar 16, 2010 | Parker Waichman LLP
A massive recall is being issued for seven brands of Boston Scientific implantable heart defibrillators.  The recall is being issued because Boston Scientific has determined that it did not get approval from federal regulators for changes to its manufacturing processes. According to a Boston Scientific press release, the company is halting sales and retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...

Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products

Jul 16, 2009 | Parker Waichman LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to use their surgical ablation products to treat the heart-rhythm defect called atrial fibrillation, according to lawsuits recently unsealed in Texas.   According to The Wall Street Journal, the lawsuits were filed by former employees of the companies.Allegations of kickbacks by medical device makers are nothing new.  For example, in...

FDA Warns of Potentially Fatal Complications from Improper Injection Procedures with ENTERYX®

Oct 18, 2005 |
Reports that serious patient injuries and death can be caused by improper injection procedures, Boston Scientific Corporation has recalled all ENTERYX® Procedure Kits and ENTERYX® Single Pack Injectors.  Prescribed for gastroesophageal reflux disease (GERD), ENTERYX® is injected by a physician into the inside muscle wall of the patient’s esophagus.The liquid then thickens into a sponge-like substance helping to block stomach acids and prevent them from entering the...

More Boston Scientific Enteryx Device News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo